Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-20

Clinical Trial Update: Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 pilot trial investigating autologous umbilical cord blood for treatment of autistic spectrum disorder in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous umbilical cord blood

Snippet

Sponsor: Sheba Medical Center | Conditions: Autistic Spectrum Disorder | Phase 2 | Status: UNKNOWN